Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Researching the Effectiveness of a Alivis, a Digital Health Application for Borderline Personality Disorder: a Randomized Controlled Trial

NCT06601907 is registered in ClinicalTrials.gov with Gaia AG as lead sponsor.

NCT NCT06601907
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06601907 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Researching the Effectiveness of a Alivis, a Digital Health Application for Borderline Personality Disorder: a Randomized Controlled Trial
Lead sponsor
Gaia AG
Phase
Not applicable
Overall status
Terminated
Start date
September 23, 2024
Completion date
July 23, 2025
Enrollment
286 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

borderline personality disorder (bpd)